Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT05401240
Active, not recruiting Not applicable

Using Cardiopulmonary Exercise Test as an Incentive to Outpatient Cardiac Rehabilitation for Acute Coronary Syndrome Survivors.

NCT05401240 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Taichung Veterans General Hospital
Phase
Not applicable
Started
2023-09-01
Last updated
2025-12-29

Condition(s) studied

Acute Coronary Syndrome

Investigational drug(s) / intervention(s)

information reveal

information reveal: the experimental group will be informed that there will be an important examination about his/her cardiopulmonary fitness condition at the outpatient department (OPD)

Study summary

Exercise-based cardiac rehabilitation is a class I recommendation for acute coronary syndrome (ACS) patients. However, participate rate of outpatient rehabilitation is quite low and remains a global issue. The study is to propose a strategy in order to encourage post-ACS patients to participate in the outpatient cardiac rehabilitation.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * acute coronary patients Exclusion Criteria: * acute illness that stayed in hospital for more than 2 weeks. * patients who received surgical intervention * severe complications (ex. respiratory failure, stroke, acute renal failure) * contraindications of cardiopulmonary exercise testing * patients who cannot perform the cardiopulmonary exercise testing

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Taichung Veterans General Hospital Taichung Taiwan

More Taichung Veterans General Hospital trials in Taiwan

3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection Margin Starting soon
Comparison of Post-operation Cardiopulmonary Capacity of Patients Underwent Conventional and Robot-assisted Coronary Artery Bypass Graft and Valve Replacement Surgery Starting soon
Point-of-Care Testing in Outpatient Diabetes Care Active, not recruiting
Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Recruiting
Optimized Diagnosis and Precision Medicine of MODY Recruiting

Other trials for the same condition

The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary Syndrome Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific Recruiting
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05401240 on ClinicalTrials.gov ↗ ← All trials in Taiwan